JPMorgan Downgrades Pacira Pharmaceuticals (PCRX) to Underweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| PACIRA (NASDAQ: PCRX) | Delayed: 36.33 -0.07 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.40 | 52 Week High | $80.25 | |||
| Open | $36.39 | 52 Week Low | $30.25 | |||
| Day High | $36.67 | P/E | N/A | |||
| Day Low | $36.31 | EPS | $-2.08 | |||
| Volume | 2,064,137 | |||||
